SMLR Company Profile and Key Details

SMLR has shown mixed momentum, losing -1.64% over the past week and -20.18% over the past quarter, though year-to-date performance is up 32.96%. Short-term trend indicators are bullishly aligned (SMA20 9.42%, SMA50 -0.25%, SMA200 -33.0%). The stock’s 14-day RSI is 52.28 (neutral), while the ATR of 2.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -69.43% below its high and over 36.58% above its low.

Semler Scientific, Inc. (NASDAQ:SMLR) closed at $20.33 USD, losing -$1.04 (-4.87%) from the previous close of $21.37. The stock is currently mid-range between its 52-week high and low $14.88 and $65.98. With a market capitalization of about $310.75 million, Semler Scientific, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.32). Key stats such as the average daily volume over the past year has been around 647.86 thousand shares, trading with heavier-than-usual volume. Headquartered in Santa Clara, CA, Semler Scientific, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Douglas Murphy-Chutorian, the company employs approximately 79 people and listed since February 21, 2014. Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.

Semler Scientific, Inc. generated EPS of $2.78 over the past year. Five-year average earnings growth is 22.23%. The latest quarter delivered EPS of $1.07. The next quarter is forecast at $nan. Next year's EPS is expected at $25.58. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $101.00 to $60.00. The high target offers 396.8% upside. The low target suggests 195.13% downside. The mean target is $80.50. This offers 295.97% upside. Semler Scientific, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -621.95%. The prior quarter beat by -5140.0%. Over the last six quarters, Apple has recorded several small beats. These include -24.27% in May 07, 2024.

Semler Scientific, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $19.14. This means the shares are trading above this model’s fair value.

Semler Scientific, Inc. has 14.80 million shares outstanding. The public float is 13.00 million shares, elevated short interest at 17.53% of float. This equals 2.29 million shares. The short ratio is 3.58 days. Institutional investors hold 74.81% of the float. Insiders own 12.15%. SEMLER ERIC holds 77.77 thousand shares, Murphy-Chutorian Douglas has 54.59 thousand shares and Pan Wayne T has 43.78 thousand shares. Over the past six months, insider transactions show net selling. They sold 41.34 thousand shares across 2 transactions.

Semler Scientific, Inc. trades at a P/E ratio of 6.24, slightly below the S&P 500 average, with a price-to-sales ratio of 8.41 and a price-to-book ratio of 0.66 suggesting the stock is closer to book value. The P/FCF stands at -0.8, also above market averages.

Our AI price prediction model suggests that Semler Scientific, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.15%, with price expected at $20.97 by January 29, 2026, within a range of $18.57 to $23.38 3-Month Outlook: Projected fall of -36.99%, reaching $12.81 by April 15, 2026, with a range of $10.63 to $14.47. 1-Year Outlook: Projected gain of 40.53%, with price at $28.57 by January 15, 2027, within a range of $25.64 to $32.75.

Semler Scientific, Inc. (NASDAQ:SMLR) shares are up 32.96% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Semler Scientific, Inc. trading at a premium to the broader market with a P/E of 6.24. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $74.88, suggesting 268.32% upside. Our AI forecast model points to short-term strength (3.15% over two weeks), a medium-term fall (-36.99% over three months), and a longer-term gain (40.53% over one year), with expected trading ranges indicating moderate volatility.